SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Coliseum Capital Management, LLC (Last) (First) (Middle) METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH (Street) STAMFORD CT 06902 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol BioScrip, Inc. [ BIOS ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 05/20/2015
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock	(1)	05/20/2015		A		10,000(1)		(2)	(2)	Common Stock	10,000(1)	$0.00(1)	10,000	I	See Footnotes(3)(4)

1. Name and Address of Reporting Person* Coliseum Capital Management, LLC (Last) (First) (Middle) METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH (Street) STAMFORD CT 06902 (City) (State) (Zip)

1. Name and Address of Reporting Person* Shackelton Christopher S (Last) (First) (Middle) METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH (Street) STAMFORD CT 06902 (City) (State) (Zip)

1. Name and Address of Reporting Person* Coliseum Capital, LLC (Last) (First) (Middle) METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH (Street) STAMFORD CT 06902 (City) (State) (Zip)

1. Name and Address of Reporting Person* COLISEUM CAPITAL PARTNERS L P (Last) (First) (Middle) METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH (Street) STAMFORD CT 06902 (City) (State) (Zip)

1. Name and Address of Reporting Person* Coliseum Capital Partners II, L.P. (Last) (First) (Middle) METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH (Street) STAMFORD CT 06902 (City) (State) (Zip)

1. Name and Address of Reporting Person* Gray Adam (Last) (First) (Middle) METRO CENTER 1 STATION PLACE, 7TH FLOOR SOUTH (Street) STAMFORD CT 06902 (City) (State) (Zip)

Explanation of Responses:

1. Each share of phantom stock is a market-based cash award which is the economic equivalent of one share of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). Each share of phantom stock is entitled to a cash payment equal to the fair market value of a share of Common Stock as of the vesting date, based on the closing market price of the Common Stock on such date.

2. The shares of phantom stock vest on the business day immediately preceding the date of the Issuer's 2016 annual meeting of stockholders, provided that Christopher Shackelton ("Shackelton") continues to serve as a director of the Issuer as of such date. If unvested on the vesting date, the shares of phantom stock expire.

3. The phantom stock was received by Shackelton in connection with his service as a member of the board of directors of the Issuer. Shackelton has agreed that all equity awards he receives for serving as a director of the Issuer shall be issued to Coliseum Capital Partners, L.P. ("CCP").

4. Shackelton and Adam Gray ("Gray") are managers of and have an ownership interest in each of (a) Coliseum Capital Management, LLC ("CCM"), the investment advisor to and a separate investment advisory account managed by CCM (the "Separate Account") and (b) Coliseum Capital, LLC ("CC"), the general partner of each of CCP and Coliseum Capital Partners II, L.P. ("CCP2") and may be deemed to have an indirect pecuniary interest in the shares held by CCP, CCP2, and the Separate Account due to CCM's right to receive performance-related fees from the Separate Account and CC's right to receive performance-related fees from CCP and CCP2. Each of the Reporting Persons disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein.

Remarks:

Shackelton is a director of the Issuer. As a result, the following persons may be deemed directors by deputization of the Issuer solely for purposes of Section 16 of the Securities Exchange Act of 1934, as amended: Gray, CCM, CC, CCP, and CCP2.

	Coliseum Capital Management, LLC, By: /s/ Christopher Shackelton, Manager	05/22/2015
	/s/ Christopher Shackelton	05/22/2015
	Coliseum Capital, LLC, By: /s/ Christopher Shackelton, Manager	05/22/2015
	Coliseum Capital Partners, L.P., By: Coliseum Capital, LLC, its General Partner, By: /s/ Christopher Shackelton, Manager	05/22/2015
	Coliseum Capital Partners II, L.P., By: Coliseum Capital, LLC, its General Partner, By: /s/ Christopher Shackelton, Manager	05/22/2015
	/s/ Adam Gray	05/22/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.